Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Nørresundby Fodklinik ApS, statsautoriseret fodterapeut Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   11.6% 10.6% 2.9% 2.2% 2.6% 4.1% 11.5% 11.5%   Credit score (0-100)   22 24 58 65 61 48 21 21   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   531 1,197 0 0 0 0 0 0   Gross profit   297 622 582 797 971 1,181 0.0 0.0   EBITDA   125 395 324 365 348 128 0.0 0.0   EBIT   41.3 260 223 241 124 48.7 0.0 0.0   Pre-tax profit (PTP)   21.4 246.3 213.7 236.9 119.9 11.7 0.0 0.0   Net earnings   15.5 192.1 164.5 184.3 93.0 8.0 0.0 0.0   Pre-tax profit without non-rec. items   21.4 246 214 237 120 11.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   284 403 302 371 670 710 0.0 0.0   Shareholders equity total   65.5 258 422 606 699 707 657 657   Interest-bearing liabilities   232 202 0.0 0.0 450 460 0.0 0.0   Balance sheet total (assets)   432 607 659 753 1,231 1,224 657 657   Net Debt   188 201 -197 -238 123 271 -657 -657     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   531 1,197 0 0 0 0 0 0   Net sales growth   0.0% 125.2% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   297 622 582 797 971 1,181 0.0 0.0   Gross profit growth   0.0% 109.1% -6.4% 36.9% 21.9% 21.6% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 -1,053.5 0.0 0.0   Balance sheet total (assets)   432 607 659 753 1,231 1,224 657 657   Balance sheet change%   0.0% 40.6% 8.5% 14.3% 63.5% -0.6% -46.3% 0.0%   Added value   124.9 394.6 323.8 364.6 248.1 1,181.1 0.0 0.0   Added value %   23.5% 33.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   201 -16 -201 -55 76 -39 -710 0   Net sales trend   0.0 1.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   23.5% 33.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   7.8% 21.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.9% 41.9% 38.3% 30.2% 12.8% 4.1% 0.0% 0.0%   Net Earnings %   2.9% 16.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   18.6% 27.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.0% 20.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.6% 50.1% 35.2% 34.1% 12.5% 4.0% 0.0% 0.0%   ROI %   13.9% 68.7% 50.6% 46.8% 14.2% 4.2% 0.0% 0.0%   ROE %   23.6% 118.9% 48.4% 35.8% 14.2% 1.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   15.2% 42.4% 64.0% 80.5% 56.8% 57.8% 100.0% 100.0%   Relative indebtedness %   68.9% 29.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   60.7% 29.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   150.9% 50.8% -60.9% -65.3% 35.3% 212.6% 0.0% 0.0%   Gearing %   354.7% 78.5% 0.0% 0.0% 64.4% 65.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   17.2% 6.5% 9.3% 0.0% 2.0% 8.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.0 1.2 2.3 1.0 0.8 0.0 0.0   Current Ratio   1.1 1.2 1.5 2.6 1.1 1.0 0.0 0.0   Cash and cash equivalent   43.7 1.7 197.2 237.9 327.5 188.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   27.8% 17.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   13.5 37.8 119.9 235.3 29.0 -2.7 0.0 0.0   Net working capital %   2.5% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0